Altiris Therapeutics

About:

Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer.

Top Investors: H.I.G. Capital, SR One, Frazier Healthcare Partners, ATDC, The Aurora Funds

Description:

Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.